Synthesis and in vitro antibacterial evaluation of novel imidazo[2′,1′:5,1]-1,2,4-triazolo[4,3-c]-quinazoline derivatives of 5-thioxo-1,2,4-triazole, 4-oxothiazolidine, and their open-chain counterparts
Synthesis and in vitro antibacterial evaluation of novel imidazo[2′,1′:5,1]-1,2,4-triazolo[4,3-c]-quinazoline derivatives of 5-thioxo-1,2,4-triazole, 4-oxothiazolidine, and their open-chain counterparts
复制标题
DOI:
10.1002/ardp.200300809
复制
发表时间:
2003-12-01
影响因子:
5.1
通讯作者:
El-Bendary, ER
中科院分区:
文献类型:
--
作者:
Nasr, MN;Gineinah, MM;El-Bendary, ER
Two novel series of imidazo[2',1':5,1]-1,2,4-triazolo[4,3-c]quinazolines bearing 5-thioxo-1,2,4-triazoles, 6a-f and 4-oxothiazolidines, 7a-f, were synthesized from corresponding thiosemicarbazide derivatives, 5a-f. The stepwise methodology applied to the preparation of compounds 5 a-f was initiated with reaction of the parent 3-amino-1,2,4-triazolo[4,3-c]quinazolines, 2, with ethyl 2-chloroacetoacetate resulting in annelation of the imidazole ring to give esters, 3 a-c. However, hydrazinolysis of these ester derivatives gave the corresponding acid hydrazides, 4a-c, which on reaction with the appropriate alkyl isothiocyanate yielded compounds 5a-f. In turn, compounds 5, were cyclized with potassium hydroxide or with ethyl bromoacetate to give the corresponding thioxotriazoles 6 and oxothiazolidines 7, respectively. All synthesized compounds were screened for their in vitro antibacterial activity against various Gram-positive and Gram-negative bacteria. Some test compounds were found to possess potent antibacterial activities. Compound, 7f, exhibited much higher potency than the reference standard ciprofloxacin, against both types of bacteria, particularly, Gram-positive organisms.